Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study
2017 · The Lancet. Gastroenterology & hepatology · 19 citations
https://doi.org/10.1016/s2468-1253(17)30048-1